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Light profoundly affects our mental and physical health. In particular, light, when
not delivered at the appropriate time, may have detrimental effects. In mammals,
light is perceived not only by rods and cones but also by a subset of retinal
ganglion cells that express the photopigment melanopsin that renders them intrinsically
photosensitive (ipRGCs). ipRGCs participate in contrast detection and play critical roles
in non-image-forming vision, a set of light responses that include circadian entrainment,
pupillary light reflex (PLR), and the modulation of sleep/alertness, and mood. ipRGCs
are also found in the human retina, and their response to light has been characterized
indirectly through the suppression of nocturnal melatonin and PLR. However, until
recently, human ipRGCs had rarely been investigated directly. This gap is progressively
being filled as, over the last years, an increasing number of studies provided descriptions
of their morphology, responses to light, and gene expression. Here, I review the progress
in our knowledge of human ipRGCs, in particular, the different morphological and
functional subtypes described so far and how they match the murine subtypes. I also
highlight questions that remain to be addressed. Investigating ipRGCs is critical as these
few cells play a major role in our well-being. Additionally, as ipRGCs display increased
vulnerability or resilience to certain disorders compared to conventional RGCs, a deeper
knowledge of their function could help identify therapeutic approaches or develop
diagnostic tools. Overall, a better understanding of how light is perceived by the human
eye will help deliver precise light usage recommendations and implement light-based
therapeutic interventions to improve cognitive performance, mood, and life quality.
Keywords: retina, retinal ganglion cell, intrinsically photosensitive ganglion cell, melanopsin (OPN4), non-visual
responses to light
INTRODUCTION
The last years have seen an increased awareness of the impact of light on health, particularly
of its detrimental effects when light is not delivered at the appropriate time. Light at night,
also called “light pollution,” is becoming a major environmental and health concern (1–4). Even
low-level light exposure from light-emitting devices, smartphones, or tablets may disrupt sleep
(5, 6). As inappropriate illumination can be detrimental to health, optimal lighting can be a simple,
cost-efficient population-level intervention to improve health: if light is delivered at the right time
and in the right amount, it can ameliorate the quality of life in the nursing home and improve
cognitive performances at school and at work (7–9).
Mure ipRGCs of the Human Retina
Both beneficial and detrimental effects of light are mediated
not only by rods and cones, the well-known photoreceptors
that serve vision but also by a third class of cells in our
retina. These cells are a subset of retinal ganglion cells
(RGCs) expressing the photopigment melanopsin that renders
them sensitive to light. They have been referred to as either
photosensitive, intrinsically photosensitive retinal ganglion cells
(pRGCs, ipRGCs), or melanopsin-expressing retinal ganglion
cells (mRGCs) according to the context, i.e., when the studies
focus on their response to light or on the presence of melanopsin
respectively. Here, for simplicity, I will use the acronym ipRGCs.
ipRGCs play a major role in what is called “non-visual” or
“non-image-forming” responses to light. These responses include
the alignment of our internal clock to the environmental
day/night cycle, the regulation of the sleep-wake cycles, of the
pupillary reflex to light (PLR), and the modulation of mood
(10–12). More recently, it has been shown that melanopsin-
driven response of ipRGCs also participates in some aspects of
vision (13–16).
Twenty years after their discovery (17, 18), ipRGCs are
well-documented in rodents and have been reviewed in depth
elsewhere (19–21). Although there are only a few thousand
ipRGCs per retina, they exhibit remarkable heterogeneity. They
differ regarding dendritic arborization, expression levels of
melanopsin, brain targets, and light response properties. In the
mouse retina, six different morphological subtypes (M1 through
M6) have been characterized and at least five functional subtypes
are described. While the M1 subtype expresses high levels of
melanopsin, the M2–M6 subtypes express lower amounts of
melanopsin and also exhibit reduced intrinsic photosensitivity.
Accordingly, each ipRGC subtype is thought to execute distinct
light-regulated functions at specific levels of light intensity or
time constants. For example, a fraction of M1 ipRGCs mediates
the photoentrainment of the circadian clock while M4 ipRGCs
are involved in the effect of light on mood. In contrast, all ipRGC
subtypes seem to project to visual structures [dLGN, superior
colliculus (SC)], and it is believed that they all participate in
some aspects of vision. Finally, while ipRGCs are the principal
conduits for all light input to the non-image-forming visual
responses, anatomical and electrophysiological evidence suggests
that ipRGCs also receive input from rod/cone photoreceptors.
In stark contrast to rodent ipRGCs, the exploration of ipRGCs
in primates and in human, in particular, was, until recently,
extremely limited. There is, however, a strong rationale to
study them. Human and mouse are respectively diurnal and
nocturnal animals. Human retina differs from the rodent retina
on several levels, from the regional specialization of the retina to
photoreceptor types and distribution (Figure 1). Human retina is
adapted for high definition, color vision. This is achieved thanks
to the fovea, a central zone of the retina (∼1.2mm of diameter),
where three types of cones are densely packed. These cones (S,
M, and L for short-, middle-, and long-wavelength cones) mostly
express a unique photopigment with absorption peaks at 430,
531, and 561 nm, respectively (26, 27). In contrast, laboratory
mice are nocturnal and their retina, devoid of fovea, is largely
dominated by rods and expresses only two types of cone opsins
[S- and M-opsin, with peak sensitivities at 360 nm and 508 nm,
respectively (28, 29) often co-expressed in the same cone (30).
As a consequence, there is a lack of appropriate murine models
for some humane ocular disorders, such as age-related macular
degeneration (31). Apart from anatomical discrepancies, there is
also the genetic gap between the two species, which may result
in different phenotypes in some cases of genetically inherited
diseases (32). Another caveat is human modern lifestyle that
results in a number of disorders such as diabetic retinopathy,
which does not naturally occur in rodents.
Fortunately, the gap of knowledge in human ipRGCs is
progressively being filled. New approaches and techniques have
allowed characterizing morphological and functional human
ipRGC subtypes, their transcriptome, and realizing that, in
several disorders, they are either more resilient or vulnerable
than conventional RGCs. The present paper reviews this recent
progress in our knowledge of human ipRGCs, briefly compares
their characteristics with those of the most studied model, the
laboratory mouse, and highlights some outstanding questions
and future challenges.
HUMAN ipRGCs COMPRISE SEVERAL
MORPHOLOGICAL SUBTYPES
Shortly after its discovery in the mouse, melanopsin was also
found in the human inner retina (33). Melanopsin expression was
detected in a subpopulation of RGCs located in the ganglion cell
layer but also sometimes displaced in the inner nuclear cell layer.
Melanopsin-expressing cells have a particular morphology with
two to four dendritic processes constituting an extensive network
throughout the retina. Melanopsin immunoreactivity is present
in the soma and neuronal processes membranes and, to some
extent, in the cytoplasm (33–35). Rare melanopsin-positive cones
were also described in the human retina (36).
The morphological characterization of ipRGCs in the human
retina has now advanced substantially; several recent studies
provided a detailed morphological description of ipRGCs in the
retina of human donors (Figure 1) (22–25, 37). In humans, the
reported number of ipRGCs varies from ∼4,000 to more than
7,000, but it remains extremely marginal (0.4–1.5%) compared to
the 1.07 million ganglion cells in the human retina (22–24, 35,
38, 39). Two distinct morphological types roughly correspond
to the M1 type of the mice, with dendrites that are primarily
or exclusively in the outer sublamina of the inner plexiform
layer (IPL), and the M2 type of the mice with dendrites that
are primarily or exclusively in the inner sublamina of the IPL
(40). The fovea is devoid of ipRGCs. The ipRGCs are most
abundant in the peri-foveal region (∼15–40 cells/mm2) and their
number declines to <5 cells/mm2 at 10mm eccentricity and
beyond (23–25); in that, they parallel the decrease of density
of RGCs from the center to periphery of the retina. Additional
morphological subtypes of ipRGCs have been reported in specific
studies including M3, M4, and types that further subdivide M1
type into standard M1, gigantic M1, displaced M1 (dM1), and
gigantic dM1 (22–25) (Figure 2). Of note, in human, but not in
themouse, dM1 constitute themajority ofM1. Importantly, these
morphological studies relied on immunostaining of melanopsin,
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FIGURE 1 | ipRGCs in the mouse and human retinas. (Upper panels) Relative spectral sensitivity of the rods, cones, and ipRGCs. (Middle panels) Diagram of murine
and human retinas displaying the differences regarding the morphological subtypes of ipRGCs, their IPL dendritic stratification, and outer retina photoreceptors.
(Lower panels) Morphological comparison between subtypes and species. Soma and dendritic tree measurements are rounded to the closest integer. Mouse data are
from Sondereker et al. (21) that compiled them from literature. Human data are from Esquiva et al. (22), Hannibal et al. (23), Liao et al. (24), and Nasir-Ahmad et al.
(25). GM1, gigantic M1; dM1, displaced M1; dGM1, displaced gigantic M1; PRL, photoreceptors layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner
plexiform layer; IPL, inner plexiform layer; GCL, ganglion cells layer.
a method that, in mice, has been shown to fail to detect all
ipRGCs [see Aranda and Schmidt (19)]. This suggests a probable
underestimation of the total number of ipRGCs and potential
bias in the reported subtype distribution.
ipRGCs BRAIN TARGETS
Mapping the projections of ipRGCs in the brain has been
instrumental to discover their multiple functions. In the mouse,
ipRGCs convey light information to more than a dozen brain
regions, including several nuclei implicated in circadian rhythms
[suprachiasmatic nucleus (SCN), intergeniculate leaflet (IGL)],
sleep and wake regulation [in the hypothalamus, the ventrolateral
preoptic area (VLPO) and lateral hypothalamus (LH), and the
centro-medial nucleus in the thalamus], PLR control [olivary
pretectal nucleus (OPN)], and mood (peri Habenula) (41–44).
Visual structures such as the dorsal lateral geniculate nucleus
(dLGN) and the superior colliculus (SC) are also targeted.
In human, the exploration of ipRGC projections is limited by
the impossibility to use the appropriate techniques, e.g., injection
of tracers or genetically encoded labels. However, Hannibal and
colleagues (35) took advantage of the fact that the pituitary
adenylate-cyclase-activating polypeptide (PACAP) is a marker
for retinohypothalamic tract (RHT) projections to the SCN in
rodents and human (45) and that PACAP is found in virtually
all ipRGCs in the retina of human to describe ipRGC putative
projections on the SCN. They found a dense terminal field of
PACAP-positive nerve fibers in the retinorecipient zone (ventral
part) of the SCN in two human donors (while no PACAP-
immunoreactive cell bodies were found in the SCN). The fibers
mainly arose from the optic chiasma and were found in close
apposition to VIP-containing neurons in the ventral SCN.
Given the impossibility to use tracers in humans, studies
in non-human primates remain essential for completing the
mapping of ipRGC central projections in the primate. Classical
retrograde tracing from the lateral geniculate complex and
the pretectum in macaque identified these areas as targets
for the ipRGCs (34). Using immunohistochemical staining of
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FIGURE 2 | Human ipRGCs morphological subtypes. (A–C) Reconstruction and pseudocoloring of ipRGCs from three separate human retina volumes based on
melanopsin immunoreactivity. Upper left subpanels illustrate the different ipRGCs detected in the volumes, their relative size, and arrangement toward each other. In
the other subpanels, each ipRGC is then identified and represented separately to appreciate the details of their dendritic arborization. dM1, displaced M1; GM1,
gigantic M1; dGM1, displaced gigantic M1. Scale bars: A, 100µm; B, 80µm; C, 50µm [Figure adapted from Hannibal et al. (23); courtesy of Dr. J. Hannibal and
Journal of Comparative Neurology].
PACAP in combination with staining for the anterograde tracer
(Cholera Toxin Fragment B) delivered by intraocular injection,
ipRGC projections to the SCN were confirmed in macaque (46).
Additionally, projections to the LGN including the pregeniculate
nucleus [which is thought to correspond to the rodents IGL
(47)], the OPN, the nucleus of the optic tract, the brachium of
the SC, and the SC were identified (46). Interestingly, in the
macaque, ipRGC projections to the dLGN emerge from both
inner and outer stratifying melanopsin cells (hence potentially
from all ipRGC subtypes), while in the mouse, the majority
of melanopsin ganglion cell innervation of the dLGN appears
to be provided only by inner stratifying cells [non-M1 cells
(41, 44, 48)]. Whether this discrepancy reflects an extended
role of ipRGCs in vision in the primate remains to be clarified.
Finally, in the mouse, ipRGC terminals are found in numerous
hypothalamic nuclei in addition to the SCN, including the VLPO,
LH, anterior hypothalamic nucleus, ventral subparaventricular
zone, and peri-supraoptic nucleus (42, 44). Retinal projections
to these hypothalamic nuclei also exist in the primate (49, 50).
However, whether these projections include ipRGCs remains to
be verified. It is not a trivial question as these nuclei often heavily
influence physiology through the control they exert on sleep,
appetite, and thermoregulation to name a few.
FUNCTIONAL PROPERTIES AND
DIVERSITY OF HUMAN ipRGCs
The first report of human RGCs direct electrophysiological
recording was published by Weinstein et al. (51). This study
measured the spectral sensitivity of two RGCs around the
photopic peak (555 nm). However, such recordings in the
human retina would then remain anecdotal until recently.
There have been as many studies, peer-reviewed articles and
non-peer-reviewed, preprint manuscripts, on the human retina
physiology over the last 2 years as in the previous 50
years (52–57).
So far, only one study has been specifically designed to
capture human RGCs’ intrinsic sensitivity and to describe
ipRGC responses to light and functional diversity (55). Overall,
the characteristic features of pharmacologically isolated human
ipRGC responses, i.e., when their response is solely driven
by melanopsin, seem similar to that of rodents and macaque
(17, 34, 58, 59). Human ipRGCs’ intrinsic responses to light
are slow, sustained over the entire stimulation, and do not
extinguish immediately after light OFF. These kinetic properties
make ipRGC responses very different from rod- and cone-
driven responses that are extremely fast (<100ms). Intrinsic
photoresponses of human ipRGCs are reversibly inhibited by
opsinamide, a drug that specifically blocks melanopsin (60).
Mure et al. also found that ipRGCs’ intrinsic sensitivity was
low; ipRGCs did not seem to respond to light intensities below
photopic level, even following dark adaptation. Their spectral
sensitivity peaked in the blue region of the spectrum (∼460 nm),
different from the peaks of human rods and cones but close to
mouse andmacaquemelanopsin peaks (17, 34) and to the human
melanopsin expressed in HEK293 cells (61). This result is also
consistent with ipRGCs’ role in human non-visual responses to
light such as nocturnal melatonin peak suppression (62, 63), PLR
(64, 65), non-cone/non-rod visual awareness (13, 66), cognition
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(67), and heart rate modulation (68) that are also maximally
sensitive to blue light.
Human ipRGCs’ response parameters and time courses
suggest that they consist of several functional groups. Mure et al.
described three ipRGC subtypes, each one displaying unique
response kinetics and sensitivity to light (Figure 3). Type 1
ipRGCs are more sensitive to light and sustain response long
after the light is turned off. Type 2 ipRGCs are less sensitive and
turn OFF faster. At low irradiance levels, type 2 ipRGCs exhibit
longer response latency to the test light pulse. Type 1 responses
are recorded 50%more frequently than Type 2 responses. A third
type of ipRGCs responded only in the presence of exogenous
chromophore (11-cis retinal) in the medium. These Type 3
cells responded more strongly, but only to the high irradiance
levels, and extinguished faster after light OFF. Altogether, the
features of Type 1, Type 2, and Type 3 ipRGCs suggest that
they could correspond to mouse ipRGC subtypes that have been
labeled M1, M2, and M4 ipRGCs, respectively (69–71). However,
the link between the human physiological and morphological
ipRGC subtypes, and their correspondence with the murine
subtypes, remains to be established. Also, Mure et al.’s study
was performed on a limited number of donors; these findings
need to be independently replicated. The effort must be pursued
to refine the results and to increase the number and diversity
of donors. Recently, light-induced melatonin suppression in the
evening, a process under ipRGCs control, has been shown to vary
up to 50 times between subjects (72). It would be interesting to
determine to which extent ipRGCs contribute to such variability
in light sensitivity (73).
TRANSCRIPTOME DIVERSITY OF HUMAN
ipRGCs
Underlying the morphological and functional diversity are
the different gene expression profiles of ipRGCs. In mice,
the first indication of the molecular heterogeneity of ipRGCs
came with the observation that all ipRGCs express the
transcription factor Brn3b except for the fraction of M1 cells
that project to the SCN (74). Thus, while all M1 ipRGCs
are morphologically and electrophysiologically similar, two
molecularly different subpopulations co-exist and innervate
different brain regions (SCN for M1 Brn3b– and OPN for
M1 Brn3b+). This additional dimension of identity is now
easily approachable. High-throughput methods [single-cell RNA
sequencing (scRNAseq) or RNAseq applied on RGCs-enriched
samples] allowed distinguishing several ipRGC subpopulations
in both mouse and primate (75–79).
In macaque and human retina, scRNAseq performed on
CD90+ cells to enrich the samples with RGCs (CD90 or Thy1 is a
cell surface protein marker of RGC class) allowed differentiating
up to 18 RGCs subpopulations (77, 78). The four most abundant
RGC clusters were easily identified as ON and OFF midget RGCs
and ON and OFF parasol RGCs that account for respectively
>80% and ∼10% of all RGCs in the primate retina. The
remaining RGC clusters each consists of∼1% or less of all RGCs.
FIGURE 3 | Human ipRGCs integrate extrinsic signals. Individual examples of
type 1, 2, and 3 ipRGCs’ responses to increasing irradiance light pulses (gray
bars, 30 s, 470 nm; from bottom to top, irradiance is 2.9 × 1011, 3.5 ×1012, 2
× 1013, and 2 × 1014 photons/cm2 per second). Red traces represent the
responses of pharmacologically isolated ipRGCs, which reflect their intrinsic
photosensitivity. In contrast, black traces report the responses from the same
cells in the absence of synaptic blockers and thus integrating input from outer
retina photoreceptors. Time course, sensitivity, and intrinsic properties of the
response differ between the ipRGC subtypes. The contribution from
rods/cones to the overall ipRGC responses to light also seems to be
subtype-specific. Interestingly, ipRGC subtypes may receive different inputs
from photoreceptors. Of note, in human, morphological and functional ipRGC
subtypes are not yet fully consolidated; here, ipRGC subtypes are labeled as in
the original study from which this figure is adapted (55).
Melanopsin was expressed at detectable levels in a few of these
RGC clusters in the peripheral retina, three in the macaque (77)
and two in human (78). In human, the authors noted a sensible
difference in expression levels of melanopsin and hypothesized
a correspondence between the cluster expressing the highest
level of melanopsin and M1 ipRGCs, which express the highest
levels of melanopsin in mice (20), while other subtypes (M2–
M6) would constitute the remaining cluster or be too rare to
be detected.
Interestingly, the comparative study of murine and macaque
retina cell transcriptomes indicates that the ganglion cells are the
less conserved retinal cell type between the two species. However,
while conventional RGCs only show weak correspondence in
terms of both diversity and distribution, ipRGCs seem to be
among the most conserved features (77, 79). This may reflect the
differences in the visual signal tracked by nocturnal and diurnal
animals and thus in the organization of their respective visual
systems. In contrast, the features of the light signal relevant to
non-visual responses such as the ambient level of light for the
circadian system are similar for most organisms and may rely on
similar cell types.
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INTEGRATION OF EXTERNAL INPUT
FROM PHOTORECEPTORS
In a similar way to conventional RGCs, ipRGCs convey
rod- and cone-initiated photoresponses and integrate these
extrinsic signals and their intrinsic photosensitivity (80, 81). The
contribution of outer retina photoreceptors to human ipRGC
signaling can be studied by comparing ipRGC responses before
and after application of synaptic blockers that isolate RGCs
from extrinsic input (55) (Figure 3). It is important to keep
in mind, however, that the photoreceptor responses may be
differentially affected by the preparation itself. For example, in
the absence of RPE in vitro, the input from rods and cones may
be diminished and their contribution may be underestimated.
In the absence of synaptic blockers, a large number of RGCs
respond to light. Most of them become silent after incubation
with blockers as conventional RGCs do not receive rod and
cone signals anymore. ipRGC responses persist; however, their
response is generally altered. More specifically, the response
threshold is higher and the latency is longer while the amplitude
is decreased. Of note, the part of rod and cone responses in the
overall response seems to be specific to the ipRGC subtypes. For
all subtypes, extrinsic input to ipRGCs shortens the response
latencies and lowers the response thresholds. However, only
for Type 2 and 3 ipRGCs did the extrinsic input account for
a significant portion of the sustained response and increase
their sensitivity. A similar observation was made in the mouse
where the contribution of rods and cones to ipRGC responses
seems inversely proportional to melanopsin photosensitivity;
while mouse M1 ipRGC responses are moderately influenced,
the M2–M5 subtype responses rely more heavily on extrinsic
inputs (82). The response of Type 3 ipRGCs, in particular,
seems to rely the most on input from rods/cones, which is
in line with the description of M4 ipRGCs (83, 84). Type 1
ipRGCs receive only minimal extrinsic inputs compared to other
subtypes. M1 ipRGCs, which may be the mouse orthologous of
human type 1 ipRGCs, are sufficient to photoentrain the clock
(74). This is consistent with the finding that cones, while they
may contribute to the entrainment of the clock in humans (85),
are not required for it (86). As mentioned above, human and
mouse cones differ in number and peak wavelength sensitivity,
which suggests different weights of their input to ipRGCs in
response to the same light stimulus. There may also be important
functional divergences. For example, short-wavelength cones and
melanopsin are antagonistic in controlling the primate PLR
but additive in the murine PLR (87, 88). This illustrates the
importance of elucidating the subtype-specific contribution of
rods and cones as they can dramatically alter ipRGC spectral
sensitivity; i.e., they can shift their action spectra from blue
toward shorter or longer wavelengths.
Overall, the rod/cone input to ipRGCs expands the dynamic
range of irradiance and temporal frequencies over which the
ipRGCs signal (17, 34, 55). The diversity in ipRGC subtypes
combined with the way they specifically integrate rod and cone
signals could explain their ability to regulate such a variety of
responses to light functioning at various time constants and
light levels.
ipRGCs IN AGING AND DISEASE
Several recent studies have highlighted the progressive loss of
ipRGCs with aging, which is aggravated in neurodegenerative
diseases (22, 89–92). A decrease in the total number of ipRGCs
and the size of dendritic arborization occurs progressively with
aging [31% loss in healthy subjects older than 70 years (22)].
However, there are conflicting reports about the functional
significance of such decline. Some reports suggest that ipRGC
response properties might show a functional compensation by
increasing their sensitivity and/or firing rate so that no significant
change in ipRGC-dependent response such as PLR is observed
in older individuals (93, 94). However, there are also reports of
reduced amplitude of circadian rhythm in body temperature and
increasing prevalence of sleep fragmentation among the elderly
(95, 96), which can be improved by bright light (8). ipRGC
responses measured directly in an old donor (>70 years) display
longer latency (i.e., it responds slower to a light pulse) and
overall shorter duration (55). While this observation needs to
be confirmed, it suggests that not only ipRGCs’ number but also
their function may be altered in aging.
The specific loss of ipRGCs observed with aging is accelerated
in Alzheimer’s and Parkinson’s diseases (AD and PD). AD and
PD patients have 25–30% fewer ipRGCs compared to healthy
age-matched controls (37, 90), and surviving ipRGCs display
dendritic processes. Protein aggregates have been observed in and
around ipRGCs of AD patients and may be the cause of altered
neuronal physiology (97). These results suggest that ipRGC
degenerationmay lead to circadian rhythm and sleep dysfunction
in neurodegenerative disorders (89, 98). In glaucoma, ipRGCs,
while initially more resilient than conventional RGCs, are lost
at advanced stages (91). Finally, a dramatic loss of ipRGCs
is observed in diabetic retinopathy; however, it correlates
with the overall loss of RGCs (92). In summary, histological
assessments show a decline in the number of ipRGCs in old
age and neurodegenerative diseases. Although some evidence
suggests that ipRGCs’ function is also altered in old age,
whether the ipRGCs’ intrinsic light response, the input of
rod and cones, and/or the abundancy of ipRGCs subtypes
are affected during aging and neurodegeneration remains to
be investigated.
Of note, ipRGCs are not always more vulnerable than
conventional RGCs; they possess a higher ability to survive
certain pathological and experimental conditions. In the
mouse, ipRGCs appear more resistant than other RGCs to
various insults, including optic nerve injury, glutamate-induced
excitotoxicity, and early-stage glaucoma (99, 100). In human
patients, ipRGCs resist neurodegeneration in two inherited
mitochondrial disorders that cause blindness: Leber hereditary
optic neuropathy and dominant optic atrophy (101). This ability
seems to be independent from melanopsin expression per se
as ipRGCs’ resilience is preserved in a mouse model bearing
the mutation causing dominant optic atrophy and lacking
melanopsin (102). Specific metabolic properties, such as higher
mitochondrial activity or content, have been hypothesized as
potential neuroprotective mechanisms. However, the reason why
ipRGCs are relatively spared is still not well=understood.
Frontiers in Neurology | www.frontiersin.org 6 March 2021 | Volume 12 | Article 636330
Mure ipRGCs of the Human Retina
The peculiar behavior of ipRGCs (i.e., increased vulnerability
or resilience to certain disorders) compared to conventional
RGCs has important implications. First, a better molecular
characterization of each ipRGC subtype across aging and diseases
will allow identifying the expression programs associated with
differential cell survival and will provide therapeutic targets
to diminish the loss of vision following optic nerve injury
or ocular disease (100). Then, ipRGCs could be a promising
marker to assess CNS disorders, corroborating the old saying
that the eyes are a window to the soul (103, 104). The idea is
appealing when one considers that PLR is a cost-efficient, fast,
non-invasive readout of ipRGCs’ function (64, 65). The PLR
assay is now considered an emerging method to assess retinal
and CNS disorders (105, 106) and has been suggested in the
context of neurodegeneration as potential diagnostic or follow-
up tools (107, 108). This translation has been unsuccessful with
AD so far (109, 110), but this may just emphasize the need
for direct measurements of ipRGCs’ function in patient donors.
These data would allow precisely pointing out the part of the
response that is altered and designing more suited stimulation
protocols that target it. A limitation might be that PLR relies on,
and consequently will inform only on, specific ipRGC subtypes
(part of M1 and M2 ipRGCs); it cannot be generalized as a
proxy for all ipRGCs and thus will not be predictive of all
ipRGC-dependent disorders.
CONCLUDING REMARKS
Knowledge of human ipRGCs is now catching up with what
we know of these cells in the mouse. To date, these results
emerge from a still limited number of labs; they would need to be
replicated. Some points also remain to be clarified; for example,
regarding the existing ipRGC’s populations. Does theM3 subtype
detected in some studies constitute a real ipRGC’s subpopulation
in human (22) or are the few resembling cells just marginal
between M1 and M2 (24)? M4 are only described by one group
(23) while M5 and M6 ipRGCs have not been described yet in
the human retina. Does it mean that these ipRGC subtypes do
not exist, are not morphologically distinct or too rare, and may
be discovered later as in the mouse? Then, how do the projection
maps compare? ipRGCs seem to target the same visual structures
in both mouse and human while the subtypes of cells are
not necessarily the same. Whether the numerous hypothalamic
projections observed in themouse translate in human (other than
the SCN) need to be confirmed. This is particularly important
given the control exerted by the hypothalamus over the body
homeostasis and behaviors. Finally, a challenge that applies
not only to human ipRGCs but also to the field, in general,
is to consolidate ipRGC subtype classification by reconciling
morphological, functional, and transcriptional identities. New
approaches like patch-seq that combines scRNA-seq profiling
with electrophysiological and morphological characterization of
individual neurons may be an approach to consider (111, 112).
This would constitute the first step toward completing the
assignment of a specific function (and potential role in disorders)
to each ipRGC subtype and fully elucidating both the circuits up-
and downstream of each ipRGC subtype.
The differences that emerged between mouse and primate
highlight the compelling need to include human donor retina
in the standard models. Non-human primates remain necessary
for some studies like mapping the projections. However, they
are not advantageous ethically or economically over human
preparations and consequently do not allow for a larger sample
size. Furthermore, the tissue collection can be planned and
operated within similar delays in monkey and human, at least
for the surgical samples. The parameters affecting the fitness
of the preparation may thus be controlled (hypoxia delay, pH,
or nutrients) (52, 53). Human ipRGC exploration may also
include the development of additional human ex vivo and in
vitro models such as long-term culture of retina or retina
organoids. Some results are very encouraging as retina organoids
are photosensitive, organized in layers, and display a cellular
diversity that partly recapitulates the diversity of functional
peripheral retina (53).
There is a strong incentive to pursue these efforts as this
handful of cells plays a major role in our physiology, cognitive
performances, and overall well-being. Also, as progress in
lighting science now allows for precise manipulation of quality,
quantity, and timing of light, understanding how ipRGCs
operate in the human eye in health and diseases will enable
new applications. For example, the insights could be used to
design indoor lights that offer better day–night synchronization
or which improve our moods. It will offer a framework for
improving the “spectral diet” of human at home, at work, or in
public spaces (113).
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